Profile - To The Moon

vttoh

Posts · 13Posts · 13
Following · 0Following · 0
Followers · 0Followers · 0

- vttohvttoh
  ·2022-04-30
  Stuck, losses, bought at high.. now so low...
  Sorry, this post has been deleted
  3.53K Comment
  4
  Share
  Report
- vttohvttoh
  ·2022-03-23
  Yes, thanks for the positive write up..
  Sorry, this post has been deleted
  0 Comment
  Like
  Share
  Report
- vttohvttoh
  ·2022-03-17
  Really big diff the highest and lowest within 6 months... yoyo. Indeed stunning...
  Sorry, this post has been deleted
  3.97K Comment
  3
  Share
  Report
- vttohvttoh
  ·2022-02-01
  Wait and see. Festive CNY for Asian countires....
  Sorry, this post has been deleted
  0 Comment
  Like
  Share
  Report
- vttohvttoh
  ·2022-01-13
  Okay
  Adagio Therapeutics shares jumped 22% in premarket trading
  Adagio Therapeutics shares jumped 22% in premarket trading. Its lead monoclonal antibody (mAb), has
  Adagio Therapeutics shares jumped 22% in premarket trading
  4.32K Comment
  3
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"4101538323380760","uuid":"4101538323380760","gmtCreate":1638493558972,"gmtModify":1653062293719,"name":"vttoh","pinyin":"vttoh","introduction":"","introductionEn":null,"signature":"","avatar":"https://community-static.tradeup.com/news/bc97cdf909c5a5438bfe35c2968b6537","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":6,"tweetSize":13,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.01.12","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9069621062,"gmtCreate":1651283297995,"gmtModify":1676534883964,"author":{"id":"4101538323380760","authorId":"4101538323380760","name":"vttoh","avatar":"https://community-static.tradeup.com/news/bc97cdf909c5a5438bfe35c2968b6537","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4101538323380760","idStr":"4101538323380760"},"themes":[],"title":"","htmlText":"Stuck, losses, bought at high.. now so low...","listText":"Stuck, losses, bought at high.. now so low...","text":"Stuck, losses, bought at high.. now so low...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9069621062","repostId":"1176395936","repostType":4,"isVote":1,"tweetType":1,"viewCount":3527,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9037967726,"gmtCreate":1648008492898,"gmtModify":1676534292516,"author":{"id":"4101538323380760","authorId":"4101538323380760","name":"vttoh","avatar":"https://community-static.tradeup.com/news/bc97cdf909c5a5438bfe35c2968b6537","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4101538323380760","idStr":"4101538323380760"},"themes":[],"title":"","htmlText":"Yes, thanks for the positive write up..","listText":"Yes, thanks for the positive write up..","text":"Yes, thanks for the positive write up..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9037967726","repostId":"2221979490","repostType":4,"isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9035917576,"gmtCreate":1647484293124,"gmtModify":1676534236327,"author":{"id":"4101538323380760","authorId":"4101538323380760","name":"vttoh","avatar":"https://community-static.tradeup.com/news/bc97cdf909c5a5438bfe35c2968b6537","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4101538323380760","idStr":"4101538323380760"},"themes":[],"title":"","htmlText":"Really big diff the highest and lowest within 6 months...&nbsp; yoyo. Indeed stunning...","listText":"Really big diff the highest and lowest within 6 months...&nbsp; yoyo. Indeed stunning...","text":"Really big diff the highest and lowest within 6 months... yoyo. Indeed stunning...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035917576","repostId":"1116449735","repostType":4,"isVote":1,"tweetType":1,"viewCount":3969,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091093338,"gmtCreate":1643726588855,"gmtModify":1676533848854,"author":{"id":"4101538323380760","authorId":"4101538323380760","name":"vttoh","avatar":"https://community-static.tradeup.com/news/bc97cdf909c5a5438bfe35c2968b6537","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4101538323380760","idStr":"4101538323380760"},"themes":[],"title":"","htmlText":"Wait and see. Festive CNY for Asian countires....","listText":"Wait and see. Festive CNY for Asian countires....","text":"Wait and see. Festive CNY for Asian countires....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091093338","repostId":"1114695719","repostType":4,"isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002486872,"gmtCreate":1642069998236,"gmtModify":1676533677814,"author":{"id":"4101538323380760","authorId":"4101538323380760","name":"vttoh","avatar":"https://community-static.tradeup.com/news/bc97cdf909c5a5438bfe35c2968b6537","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4101538323380760","idStr":"4101538323380760"},"themes":[],"title":"","htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002486872","repostId":"1155797604","repostType":4,"repost":{"id":"1155797604","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642067062,"share":"https://ttm.financial/m/news/1155797604?lang=en_US&edition=fundamental","pubTime":"2022-01-13 17:44","market":"us","language":"en","title":"Adagio Therapeutics shares jumped 22% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1155797604","media":"Tiger Newspress","summary":"Adagio Therapeutics shares jumped 22% in premarket trading. Its lead monoclonal antibody (mAb), has ","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/ADGI\">Adagio Therapeutics</a> shares jumped 22% in premarket trading. Its lead monoclonal antibody (mAb), has neutralization activity against the Omicron variant.<img src=\"https://static.tigerbbs.com/835a5e8d01f56d120170cb4189fb383f\" tg-width=\"1026\" tg-height=\"634\" width=\"100%\" height=\"auto\"/>Adagio Therapeutics summarized recent findings reported in three separate publications that show ADG20, its lead monoclonal antibody (mAb), has neutralization activity against the Omicron (B.1.1.529) variant of SARS-CoV-2, and outlined initiatives to address current and future SARS-CoV-2 variants of concern.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adagio Therapeutics shares jumped 22% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdagio Therapeutics shares jumped 22% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-13 17:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><a href=\"https://laohu8.com/S/ADGI\">Adagio Therapeutics</a> shares jumped 22% in premarket trading. Its lead monoclonal antibody (mAb), has neutralization activity against the Omicron variant.<img src=\"https://static.tigerbbs.com/835a5e8d01f56d120170cb4189fb383f\" tg-width=\"1026\" tg-height=\"634\" width=\"100%\" height=\"auto\"/>Adagio Therapeutics summarized recent findings reported in three separate publications that show ADG20, its lead monoclonal antibody (mAb), has neutralization activity against the Omicron (B.1.1.529) variant of SARS-CoV-2, and outlined initiatives to address current and future SARS-CoV-2 variants of concern.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155797604","content_text":"Adagio Therapeutics shares jumped 22% in premarket trading. Its lead monoclonal antibody (mAb), has neutralization activity against the Omicron variant.Adagio Therapeutics summarized recent findings reported in three separate publications that show ADG20, its lead monoclonal antibody (mAb), has neutralization activity against the Omicron (B.1.1.529) variant of SARS-CoV-2, and outlined initiatives to address current and future SARS-CoV-2 variants of concern.","news_type":1,"symbols_score_info":{"ADGI":0.9}},"isVote":1,"tweetType":1,"viewCount":4316,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}